HK1199028A1 - Anti-viral compounds - Google Patents
Anti-viral compoundsInfo
- Publication number
- HK1199028A1 HK1199028A1 HK14112535.1A HK14112535A HK1199028A1 HK 1199028 A1 HK1199028 A1 HK 1199028A1 HK 14112535 A HK14112535 A HK 14112535A HK 1199028 A1 HK1199028 A1 HK 1199028A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- viral compounds
- viral
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161542056P | 2011-09-30 | 2011-09-30 | |
| PCT/US2012/057562 WO2013049352A2 (fr) | 2011-09-30 | 2012-09-27 | Composés anti-viraux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1199028A1 true HK1199028A1 (en) | 2015-06-19 |
Family
ID=47996737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14112535.1A HK1199028A1 (en) | 2011-09-30 | 2014-12-12 | Anti-viral compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20140227321A1 (fr) |
| EP (1) | EP2748169A4 (fr) |
| JP (1) | JP2014528410A (fr) |
| KR (1) | KR20140071454A (fr) |
| CN (1) | CN103842364A (fr) |
| AU (1) | AU2012315988A1 (fr) |
| BR (1) | BR112014007781A2 (fr) |
| CA (1) | CA2862895A1 (fr) |
| HK (1) | HK1199028A1 (fr) |
| IL (2) | IL231781A0 (fr) |
| MX (1) | MX2014003889A (fr) |
| SG (1) | SG11201401082XA (fr) |
| TW (1) | TW201321385A (fr) |
| WO (1) | WO2013049352A2 (fr) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2118074T3 (pl) | 2007-02-01 | 2014-06-30 | Resverlogix Corp | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego |
| US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
| WO2012088266A2 (fr) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3 |
| US8846656B2 (en) | 2011-07-22 | 2014-09-30 | Novartis Ag | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| SG11201408238WA (en) | 2012-06-13 | 2015-01-29 | Incyte Corp | Substituted tricyclic compounds as fgfr inhibitors |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| EA035095B1 (ru) | 2013-04-19 | 2020-04-27 | Инсайт Холдингс Корпорейшн | Бициклические гетероциклы в качестве ингибиторов fgfr |
| CA2923075C (fr) | 2013-09-12 | 2022-07-26 | Alios Biopharma, Inc. | Composes d'aza-pyridone et leurs utilisations |
| JP6466924B2 (ja) | 2013-10-04 | 2019-02-06 | インフィニティー ファーマシューティカルズ， インコーポレイテッド | 複素環式化合物及びその使用 |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| DK3119397T3 (da) | 2014-03-19 | 2022-03-28 | Infinity Pharmaceuticals Inc | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser |
| WO2016054491A1 (fr) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Composés hétérocycliques et leurs utilisations |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| WO2016107832A1 (fr) | 2014-12-30 | 2016-07-07 | F. Hoffmann-La Roche Ag | Nouvelles tétrahydropyridopyrimidines et tétrahydropyridopyridines pour le traitement et la prévention d'une infection par le virus de l'hépatite b |
| CR20170390A (es) | 2015-02-20 | 2017-10-23 | Incyte Holdings Corp | Heterociclos biciclicos como inhibidores de fgfr |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| CA2979216A1 (fr) | 2015-03-11 | 2016-09-15 | Alios Biopharma, Inc. | Composes d'aza-pyridone et leurs utilisations |
| CN114984016A (zh) | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
| WO2016177655A1 (fr) | 2015-05-04 | 2016-11-10 | F. Hoffmann-La Roche Ag | Tétrahydropyridopyrimidines et tétrahydropyridopyridines comme inhibiteurs d'ag hbs (antigène de surface du virus de l'hépatite b) et production d'adn de vhb pour le traitement d'infections par le virus de l'hépatite b |
| KR20180058741A (ko) | 2015-09-14 | 2018-06-01 | 인피니티 파마슈티칼스, 인코포레이티드 | 이소퀴놀리논의 고체형, 그의 제조 방법, 이를 포함하는 조성물 및 이를 사용하는 방법 |
| WO2017161116A1 (fr) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues de composés isoquinolinone et quinazolinone et leurs utilisations comme inhibiteurs de la kinase pi3k |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| JP6821716B2 (ja) | 2016-06-29 | 2021-01-27 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂ型肝炎ウイルス感染の処置および予防のための新規のジヒドロピロロピリミジン |
| WO2018001952A1 (fr) | 2016-06-29 | 2018-01-04 | F. Hoffmann-La Roche Ag | Nouvelles tétrahydropyridopyrimidines pour le traitement et la prophylaxie d'une infection par le vhb |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| SG11202010636VA (en) | 2018-05-04 | 2020-11-27 | Incyte Corp | Solid forms of an fgfr inhibitor and processes for preparing the same |
| WO2019213506A1 (fr) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Sels d'un inhibiteur de fgfr |
| US20220106276A1 (en) | 2018-12-10 | 2022-04-07 | Ideaya Biosciences, Inc. | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| WO2021007269A1 (fr) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
| CR20220169A (es) | 2019-10-14 | 2022-10-27 | Incyte Corp | Heterociclos bicíclicos como inhibidores de fgfr |
| WO2021076728A1 (fr) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
| JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤としての三環式複素環 |
| CA3162010A1 (fr) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Derives d'un inhibiteur de fgfr |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US11691971B2 (en) | 2020-06-19 | 2023-07-04 | Incyte Corporation | Naphthyridinone compounds as JAK2 V617F inhibitors |
| WO2021257863A1 (fr) | 2020-06-19 | 2021-12-23 | Incyte Corporation | Composés de pyrrolotriazine utilisés en tant qu'inhibiteurs de v617f de jak2 |
| WO2022006456A1 (fr) | 2020-07-02 | 2022-01-06 | Incyte Corporation | Composés de pyridone tricyclique en tant qu'inhibiteurs de v617f de jak2 |
| WO2022006457A1 (fr) | 2020-07-02 | 2022-01-06 | Incyte Corporation | Composés d'urée tricycliques en tant qu'inhibiteurs de v617f de jak2 |
| WO2022046989A1 (fr) | 2020-08-27 | 2022-03-03 | Incyte Corporation | Composés d'urée tricycliques en tant qu'inhibiteurs de v617f de jak2 |
| CN114524810B (zh) * | 2020-11-21 | 2023-12-01 | 上海凌达生物医药有限公司 | 一类嘧啶并杂环类化合物、制备方法和用途 |
| US11919908B2 (en) | 2020-12-21 | 2024-03-05 | Incyte Corporation | Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors |
| US11958861B2 (en) | 2021-02-25 | 2024-04-16 | Incyte Corporation | Spirocyclic lactams as JAK2 V617F inhibitors |
| CA3220274A1 (fr) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Heterocycles tricycliques en tant qu'inhibiteurs de fgfr |
| AU2022380979A1 (en) | 2021-11-02 | 2024-06-06 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000065885A (ko) * | 1999-04-10 | 2000-11-15 | 최승주 | 항바이러스성 피리미딘다이온 유도체 및 그 제조방법 |
| CA2590294A1 (fr) * | 2004-12-13 | 2006-06-22 | Sunesis Pharmaceuticals, Inc. | Pyridopyrimidinones, dihydropyrimidopyrimidinones et pteridinones utiles en tant qu'inhibiteurs des kinases raf |
| KR20090115953A (ko) * | 2007-03-06 | 2009-11-10 | 노파르티스 아게 | 염증성 또는 알레르기성 상태의 치료에 적합한 바이시클릭 유기 화합물 |
| CA2688194A1 (fr) * | 2007-05-23 | 2008-12-04 | Siga Technologies, Inc. | Medicaments antiviraux pour le traitement et la prevention d'une infection par la dengue |
| CA2709784A1 (fr) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Procede permettant de modifier la duree de vie d'organismes eucaryotes |
| PT2268642E (pt) * | 2008-04-23 | 2015-06-02 | Gilead Sciences Inc | Análogos de carba-nulceósidos 1¿-substituídos para tratamento antiviral |
| CA2798209A1 (fr) * | 2010-04-23 | 2011-10-27 | Kineta, Inc. | Composes antiviraux |
| EP2560656A4 (fr) * | 2010-04-23 | 2013-11-27 | Kineta Inc | Composés antiviraux |
-
2012
- 2012-09-27 US US14/348,520 patent/US20140227321A1/en not_active Abandoned
- 2012-09-27 KR KR1020147011234A patent/KR20140071454A/ko not_active Application Discontinuation
- 2012-09-27 AU AU2012315988A patent/AU2012315988A1/en not_active Abandoned
- 2012-09-27 SG SG11201401082XA patent/SG11201401082XA/en unknown
- 2012-09-27 CN CN201280047114.0A patent/CN103842364A/zh active Pending
- 2012-09-27 MX MX2014003889A patent/MX2014003889A/es not_active Application Discontinuation
- 2012-09-27 EP EP12837518.5A patent/EP2748169A4/fr not_active Withdrawn
- 2012-09-27 JP JP2014533321A patent/JP2014528410A/ja not_active Withdrawn
- 2012-09-27 CA CA2862895A patent/CA2862895A1/fr not_active Abandoned
- 2012-09-27 BR BR112014007781A patent/BR112014007781A2/pt not_active IP Right Cessation
- 2012-09-27 WO PCT/US2012/057562 patent/WO2013049352A2/fr active Application Filing
- 2012-09-28 TW TW101136098A patent/TW201321385A/zh unknown
-
2014
- 2014-03-27 IL IL231781A patent/IL231781A0/en not_active IP Right Cessation
- 2014-12-12 HK HK14112535.1A patent/HK1199028A1/xx unknown
-
2015
- 2015-12-02 US US14/957,507 patent/US20160102099A1/en not_active Abandoned
-
2016
- 2016-01-11 IL IL243558A patent/IL243558A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140227321A1 (en) | 2014-08-14 |
| MX2014003889A (es) | 2014-12-10 |
| SG11201401082XA (en) | 2014-04-28 |
| US20160102099A1 (en) | 2016-04-14 |
| EP2748169A2 (fr) | 2014-07-02 |
| TW201321385A (zh) | 2013-06-01 |
| AU2012315988A1 (en) | 2014-04-10 |
| WO2013049352A3 (fr) | 2013-07-11 |
| EP2748169A4 (fr) | 2015-06-17 |
| JP2014528410A (ja) | 2014-10-27 |
| WO2013049352A2 (fr) | 2013-04-04 |
| CA2862895A1 (fr) | 2013-04-04 |
| CN103842364A (zh) | 2014-06-04 |
| IL243558A0 (en) | 2016-02-29 |
| BR112014007781A2 (pt) | 2017-04-11 |
| IL231781A0 (en) | 2014-05-28 |
| KR20140071454A (ko) | 2014-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL243558A0 (en) | Substances with antiviral activity and the use of preparations containing them | |
| IL222634A0 (en) | Anti-viral compounds | |
| GB201109763D0 (en) | Compounds | |
| GB201106395D0 (en) | Compounds | |
| EP2651920A4 (fr) | Composés anti-viraux | |
| IL222633A0 (en) | Anti-viral compounds | |
| EP2651926A4 (fr) | Composés anti-viraux | |
| EP2560636A4 (fr) | Composés antiviraux | |
| EP2651927A4 (fr) | Composés anti-viraux | |
| EP2651928A4 (fr) | Composés anti-viraux | |
| GB201107197D0 (en) | Compounds | |
| EP2651923A4 (fr) | Composés anti-viraux | |
| EP2651925A4 (fr) | Composés anti-viraux | |
| IL222635A0 (en) | Anti-viral compounds | |
| HK1199029A1 (en) | Anti-viral compounds | |
| EP2714693A4 (fr) | Composés antiviraux | |
| EP2714035A4 (fr) | Composés antiviraux | |
| EP2560635A4 (fr) | Composés antiviraux | |
| GB201110938D0 (en) | Compounds | |
| GB201105659D0 (en) | Compounds | |
| ZA201903284B (en) | Anti-viral compounds | |
| EP2560628A4 (fr) | Composés antiviraux | |
| GB201107348D0 (en) | Novel anti-viral | |
| GB201115827D0 (en) | Compounds | |
| GB201115828D0 (en) | Compounds |